Latest Report On Animal Stem Cell Therapy Market including Market Landscape, and Market size, Revenues by players, Revenues by regions, Average prices, Competitive landscape, market Dynamics and industry trends and developments during the forecast period.
The global Animal Stem Cell Therapy market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the global Animal Stem Cell Therapy market. The research study comes out as a compilation of useful guidelines for players to secure a position of strength in the global market. The authors of the report profile leading companies of the global Animal Stem Cell Therapy market, Also the details about important activities of leading players in the competitive landscape.
Key companies operating in the global Animal Stem Cell Therapy market include: Medivet Biologics LLC, VETSTEM BIOPHARMA, J-ARM, U.S. Stem Cell, Inc, VetCell Therapeutics, Celavet Inc., Magellan Stem Cells, Kintaro Cells Power, Animal Stem Care, Animal Cell Therapies, Cell Therapy Sciences, Animacel
Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :
https://www.qyresearch.com/sample-form/form/1090738/global-animal-stem-cell-therapy-market
The report predicts the size of the global Animal Stem Cell Therapy market in terms of value and volume for the forecast period 2020-2026. As per the analysis provided in the report, the global Animal Stem Cell Therapy market is expected to rise at a CAGR of xx % between 2020 and 2026 to reach a valuation of US$ xx million/billion by the end of 2026. In 2020, the global Animal Stem Cell Therapy market attained a valuation of US$ XX million/billion. The market researchers deeply analyze the global Animal Stem Cell Therapy industry landscape and the future prospects it is anticipated to create
Segmental Analysis
The report has classified the global Animal Stem Cell Therapy industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Animal Stem Cell Therapy manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Animal Stem Cell Therapy industry.
Global Animal Stem Cell Therapy Market Segment By Type:
Dogs, Horses, Others
Global Animal Stem Cell Therapy Market Segment By Application:
Veterinary Hospitals, Research Organizations
Competitive Landscape
It is important for every market participant to be familiar with the competitive scenario in the global Animal Stem Cell Therapy industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.
Key companies operating in the global Animal Stem Cell Therapy market include: Medivet Biologics LLC, VETSTEM BIOPHARMA, J-ARM, U.S. Stem Cell, Inc, VetCell Therapeutics, Celavet Inc., Magellan Stem Cells, Kintaro Cells Power, Animal Stem Care, Animal Cell Therapies, Cell Therapy Sciences, Animacel
Key questions answered in the report:
Get Full Report in your inbox within 24 hours at USD(3350):
TOC
Table of Contents 1 Animal Stem Cell Therapy Market Overview1.1 Animal Stem Cell Therapy Product Overview1.2 Animal Stem Cell Therapy Market Segment by Type1.2.1 Dogs1.2.2 Horses1.2.3 Others1.3 Global Animal Stem Cell Therapy Market Size by Type1.3.1 Global Animal Stem Cell Therapy Sales and Growth by Type1.3.2 Global Animal Stem Cell Therapy Sales and Market Share by Type (2014-2019)1.3.3 Global Animal Stem Cell Therapy Revenue and Market Share by Type (2014-2019)1.3.4 Global Animal Stem Cell Therapy Price by Type (2014-2019) 2 Global Animal Stem Cell Therapy Market Competition by Company2.1 Global Animal Stem Cell Therapy Sales and Market Share by Company (2014-2019)2.2 Global Animal Stem Cell Therapy Revenue and Share by Company (2014-2019)2.3 Global Animal Stem Cell Therapy Price by Company (2014-2019)2.4 Global Top Players Animal Stem Cell Therapy Manufacturing Base Distribution, Sales Area, Product Types2.5 Animal Stem Cell Therapy Market Competitive Situation and Trends2.5.1 Animal Stem Cell Therapy Market Concentration Rate2.5.2 Global Animal Stem Cell Therapy Market Share of Top 5 and Top 10 Players2.5.3 Mergers & Acquisitions, Expansion 3 Animal Stem Cell Therapy Company Profiles and Sales Data3.1 Medivet Biologics LLC3.1.1 Company Basic Information, Manufacturing Base and Competitors3.1.2 Animal Stem Cell Therapy Product Category, Application and Specification3.1.3 Medivet Biologics LLC Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin(2014-2019)3.1.4 Main Business Overview3.2 VETSTEM BIOPHARMA3.2.1 Company Basic Information, Manufacturing Base and Competitors3.2.2 Animal Stem Cell Therapy Product Category, Application and Specification3.2.3 VETSTEM BIOPHARMA Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin(2014-2019)3.2.4 Main Business Overview3.3 J-ARM3.3.1 Company Basic Information, Manufacturing Base and Competitors3.3.2 Animal Stem Cell Therapy Product Category, Application and Specification3.3.3 J-ARM Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin(2014-2019)3.3.4 Main Business Overview3.4 U.S. Stem Cell, Inc3.4.1 Company Basic Information, Manufacturing Base and Competitors3.4.2 Animal Stem Cell Therapy Product Category, Application and Specification3.4.3 U.S. Stem Cell, Inc Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin(2014-2019)3.4.4 Main Business Overview3.5 VetCell Therapeutics3.5.1 Company Basic Information, Manufacturing Base and Competitors3.5.2 Animal Stem Cell Therapy Product Category, Application and Specification3.5.3 VetCell Therapeutics Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin(2014-2019)3.5.4 Main Business Overview3.6 Celavet Inc.3.6.1 Company Basic Information, Manufacturing Base and Competitors3.6.2 Animal Stem Cell Therapy Product Category, Application and Specification3.6.3 Celavet Inc. Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin(2014-2019)3.6.4 Main Business Overview3.7 Magellan Stem Cells3.7.1 Company Basic Information, Manufacturing Base and Competitors3.7.2 Animal Stem Cell Therapy Product Category, Application and Specification3.7.3 Magellan Stem Cells Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin(2014-2019)3.7.4 Main Business Overview3.8 Kintaro Cells Power3.8.1 Company Basic Information, Manufacturing Base and Competitors3.8.2 Animal Stem Cell Therapy Product Category, Application and Specification3.8.3 Kintaro Cells Power Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin(2014-2019)3.8.4 Main Business Overview3.9 Animal Stem Care3.9.1 Company Basic Information, Manufacturing Base and Competitors3.9.2 Animal Stem Cell Therapy Product Category, Application and Specification3.9.3 Animal Stem Care Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin(2014-2019)3.9.4 Main Business Overview3.10 Animal Cell Therapies3.10.1 Company Basic Information, Manufacturing Base and Competitors3.10.2 Animal Stem Cell Therapy Product Category, Application and Specification3.10.3 Animal Cell Therapies Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin(2014-2019)3.10.4 Main Business Overview3.11 Cell Therapy Sciences3.12 Animacel 4 Animal Stem Cell Therapy Market Status and Outlook by Regions4.1 Global Market Status and Outlook by Regions4.1.1 Global Animal Stem Cell Therapy Market Size and CAGR by Regions4.1.2 North America4.1.3 Asia-Pacific4.1.4 Europe4.1.5 South America4.1.6 Middle East and Africa4.2 Global Animal Stem Cell Therapy Sales and Revenue by Regions4.2.1 Global Animal Stem Cell Therapy Sales and Market Share by Regions (2014-2019)4.2.2 Global Animal Stem Cell Therapy Revenue and Market Share by Regions (2014-2019)4.2.3 Global Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin (2014-2019)4.3 North America Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin4.3.1 United States4.3.2 Canada4.3.3 Mexico4.4 Europe Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin4.4.1 Germany4.4.2 UK4.4.3 France4.4.4 Italy4.4.5 Russia4.4.6 Turkey4.5 Asia-Pacific Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin4.5.1 China4.5.2 Japan4.5.3 Korea4.5.4 Southeast Asia4.5.4.1 Indonesia4.5.4.2 Thailand4.5.4.3 Malaysia4.5.4.4 Philippines4.5.4.5 Vietnam4.5.5 India4.5.6 Australia4.6 South America Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin4.6.1 Brazil4.7 Middle East and Africa Animal Stem Cell Therapy Sales, Revenue, Price and Gross Margin4.7.1 Egypt4.7.2 GCC Countries 5 Animal Stem Cell Therapy Application/End Users5.1 Animal Stem Cell Therapy Segment by Application5.1.1 Veterinary Hospitals5.1.2 Research Organizations5.2 Global Animal Stem Cell Therapy Product Segment by Application5.2.1 Global Animal Stem Cell Therapy Sales by Application5.2.2 Global Animal Stem Cell Therapy Sales and Market Share by Application (2014-2019) 6 Global Animal Stem Cell Therapy Market Forecast6.1 Global Animal Stem Cell Therapy Sales, Revenue Forecast (2019-2025)6.1.1 Global Animal Stem Cell Therapy Sales and Growth Rate Forecast (2019-2025)6.1.1 Global Animal Stem Cell Therapy Revenue and Growth Rate Forecast (2019-2025)6.2 Global Animal Stem Cell Therapy Forecast by Regions6.2.1 North America Animal Stem Cell Therapy Sales and Revenue Forecast (2019-2025)6.2.2 Europe Animal Stem Cell Therapy Sales and Revenue Forecast (2019-2025)6.2.3 Asia-Pacific Animal Stem Cell Therapy Sales and Revenue Forecast (2019-2025)6.2.3.1 China6.2.3.2 Japan6.2.3.3 Korea6.2.3.4 Southeast Asia6.2.3.5 India6.2.3.6 Australia6.2.4 South America Animal Stem Cell Therapy Sales and Revenue Forecast (2019-2025)6.2.5 Middle East and Africa Animal Stem Cell Therapy Sales and Revenue Forecast (2019-2025)6.2.5.1 Egypt6.2.5.2 GCC Countries6.3 Animal Stem Cell Therapy Forecast by Type6.3.1 Global Animal Stem Cell Therapy Sales and Revenue Forecast by Type (2019-2025)6.3.2 Dogs Gowth Forecast6.3.3 Horses Gowth Forecast6.4 Animal Stem Cell Therapy Forecast by Application6.4.1 Global Animal Stem Cell Therapy Sales Forecast by Application (2019-2025)6.4.2 Global Animal Stem Cell Therapy Forecast in Veterinary Hospitals6.4.3 Global Animal Stem Cell Therapy Forecast in Research Organizations 7 Animal Stem Cell Therapy Upstream Raw Materials7.1 Animal Stem Cell Therapy Key Raw Materials7.1.1 Key Raw Materials7.1.2 Key Raw Materials Price7.1.3 Raw Materials Key Suppliers7.2 Manufacturing Cost Structure7.2.1 Raw Materials7.2.2 Labor Cost7.2.3 Manufacturing Expenses7.3 Animal Stem Cell Therapy Industrial Chain Analysis 8 Marketing Strategy Analysis, Distributors8.1 Marketing Channel8.1.1 Direct Marketing8.1.2 Indirect Marketing8.1.3 Marketing Channel Development Trend8.2 Distributors8.3 Downstream Customers 9 Research Findings and Conclusion AppendixMethodology/Research ApproachResearch Programs/DesignMarket Size EstimationMarket Breakdown and Data TriangulationData SourceSecondary SourcesPrimary SourcesDisclaimer
About Us
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Read the original:
Animal Stem Cell Therapy Market Outlook, Regional Analysis, key Drivers and Restraints, by Product, Top Players and Forecast Analysis 2020-2026 -...
- 001 International Stem Cell Corporation Provides Strategic Update on its Skin Care Program [Last Updated On: April 10th, 2010] [Originally Added On: April 10th, 2010]
- 002 International Stem Cell Corporation Provides Strategic Update on its Skin Care Program [Last Updated On: April 11th, 2010] [Originally Added On: April 11th, 2010]
- 003 CSC news roundup 2010-04-11 [Last Updated On: April 12th, 2010] [Originally Added On: April 12th, 2010]
- 004 CSC news roundup 2010-04-11 [Last Updated On: April 12th, 2010] [Originally Added On: April 12th, 2010]
- 005 International Stem Cell Corporation Engages Leading Immunogeneticists to Advance its Industry-first, Immune-matched Stem Cells [Last Updated On: April 14th, 2010] [Originally Added On: April 14th, 2010]
- 006 International Stem Cell Corporation Engages Leading Immunogeneticists to Advance its Industry-first, Immune-matched Stem Cells [Last Updated On: April 14th, 2010] [Originally Added On: April 14th, 2010]
- 007 MicroRNA therapy could be a powerful tool to correct the CSC dysregulation? [Last Updated On: April 17th, 2010] [Originally Added On: April 17th, 2010]
- 008 MicroRNA therapy could be a powerful tool to correct the CSC dysregulation? [Last Updated On: April 17th, 2010] [Originally Added On: April 17th, 2010]
- 009 CSC news links 2010-04-18 [Last Updated On: April 19th, 2010] [Originally Added On: April 19th, 2010]
- 010 CSC news links 2010-04-18 [Last Updated On: April 19th, 2010] [Originally Added On: April 19th, 2010]
- 011 Sessions on CSC Therapeutics at AACR10 [Last Updated On: April 27th, 2010] [Originally Added On: April 27th, 2010]
- 012 Sessions on CSC Therapeutics at AACR10 [Last Updated On: April 27th, 2010] [Originally Added On: April 27th, 2010]
- 013 More about presentations at AACR10 [Last Updated On: May 2nd, 2010] [Originally Added On: May 2nd, 2010]
- 014 CSC news links 2010-05-01 [Last Updated On: May 2nd, 2010] [Originally Added On: May 2nd, 2010]
- 015 More about presentations at AACR10 [Last Updated On: May 2nd, 2010] [Originally Added On: May 2nd, 2010]
- 016 CSC news links 2010-05-01 [Last Updated On: May 2nd, 2010] [Originally Added On: May 2nd, 2010]
- 017 International Stem Cell Corporation Signs Financing Agreement [Last Updated On: May 6th, 2010] [Originally Added On: May 6th, 2010]
- 018 International Stem Cell Corporation Signs Financing Agreement [Last Updated On: May 6th, 2010] [Originally Added On: May 6th, 2010]
- 019 CSC news links 2010-05-08 [Last Updated On: May 9th, 2010] [Originally Added On: May 9th, 2010]
- 020 CSC news links 2010-05-08 [Last Updated On: May 9th, 2010] [Originally Added On: May 9th, 2010]
- 021 International Stem Cell and Absorption Systems Confirm Results Showing Stem Cell Derived Corneal Tissue as an Alternative to Animals for Drug Testing [Last Updated On: May 12th, 2010] [Originally Added On: May 12th, 2010]
- 022 International Stem Cell and Absorption Systems Confirm Results Showing Stem Cell Derived Corneal Tissue as an Alternative to Animals for Drug Testing [Last Updated On: May 12th, 2010] [Originally Added On: May 12th, 2010]
- 023 Generic drug a potential treatment for glioblastoma? [Last Updated On: May 14th, 2010] [Originally Added On: May 14th, 2010]
- 024 Generic drug a potential treatment for glioblastoma? [Last Updated On: May 14th, 2010] [Originally Added On: May 14th, 2010]
- 025 US Patent: Isolation and use of solid tumor stem cells [Last Updated On: May 18th, 2010] [Originally Added On: May 18th, 2010]
- 026 US Patent: Isolation and use of solid tumor stem cells [Last Updated On: May 18th, 2010] [Originally Added On: May 18th, 2010]
- 027 International Stem Cell Corporation and The Automation Partnership Enter into Strategic Alliance to Automate Cornea Tissue Production [Last Updated On: May 19th, 2010] [Originally Added On: May 19th, 2010]
- 028 International Stem Cell Corporation and The Automation Partnership Enter into Strategic Alliance to Automate Cornea Tissue Production [Last Updated On: May 19th, 2010] [Originally Added On: May 19th, 2010]
- 029 An evolving concept of CSC in tumor biology [Last Updated On: May 21st, 2010] [Originally Added On: May 21st, 2010]
- 030 An evolving concept of CSC in tumor biology [Last Updated On: May 21st, 2010] [Originally Added On: May 21st, 2010]
- 031 International Stem Cell Corporation Moves International Cornea Development Program Forward [Last Updated On: May 26th, 2010] [Originally Added On: May 26th, 2010]
- 032 International Stem Cell Corporation Moves International Cornea Development Program Forward [Last Updated On: May 26th, 2010] [Originally Added On: May 26th, 2010]
- 033 Phase I clinical trial of ICT-107 [Last Updated On: June 3rd, 2010] [Originally Added On: June 3rd, 2010]
- 034 Phase I clinical trial of ICT-107 [Last Updated On: June 3rd, 2010] [Originally Added On: June 3rd, 2010]
- 035 CSCs responsible for metastasis identified [Last Updated On: June 6th, 2010] [Originally Added On: June 6th, 2010]
- 036 CSCs responsible for metastasis identified [Last Updated On: June 6th, 2010] [Originally Added On: June 6th, 2010]
- 037 International Stem Cell Corporation's Parthenogenetic Stem Cell Patent is Approved by the United States Patent and Trademark Office [Last Updated On: June 9th, 2010] [Originally Added On: June 9th, 2010]
- 038 International Stem Cell Corporation's Parthenogenetic Stem Cell Patent is Approved by the United States Patent and Trademark Office [Last Updated On: June 9th, 2010] [Originally Added On: June 9th, 2010]
- 039 International Stem Cell Corporation Announces Company Update Conference Call. ISCO Chairman Kenneth Aldrich to Discuss 'Status of the Company' [Last Updated On: June 10th, 2010] [Originally Added On: June 10th, 2010]
- 040 International Stem Cell Corporation Announces Company Update Conference Call. ISCO Chairman Kenneth Aldrich to Discuss 'Status of the Company' [Last Updated On: June 10th, 2010] [Originally Added On: June 10th, 2010]
- 041 Decitabine may target ovarian CSCs? [Last Updated On: June 14th, 2010] [Originally Added On: June 14th, 2010]
- 042 Decitabine may target ovarian CSCs? [Last Updated On: June 14th, 2010] [Originally Added On: June 14th, 2010]
- 043 New Article from North County Times - BIOTECH: International Stem Cell Clears Debt, Gets Patent [Last Updated On: June 17th, 2010] [Originally Added On: June 17th, 2010]
- 044 New Article from North County Times - BIOTECH: International Stem Cell Clears Debt, Gets Patent [Last Updated On: June 17th, 2010] [Originally Added On: June 17th, 2010]
- 045 Patent application: Levels of Oct1 as a method of identifying CSCs [Last Updated On: June 18th, 2010] [Originally Added On: June 18th, 2010]
- 046 Patent application: Levels of Oct1 as a method of identifying CSCs [Last Updated On: June 18th, 2010] [Originally Added On: June 18th, 2010]
- 047 OncoMed Has 'Wnt' in its Sails [Last Updated On: June 21st, 2010] [Originally Added On: June 21st, 2010]
- 048 OncoMed Has 'Wnt' in its Sails [Last Updated On: June 21st, 2010] [Originally Added On: June 21st, 2010]
- 049 International Stem Cell Corporation Names Charles J. Casamento to Board of Directors [Last Updated On: June 23rd, 2010] [Originally Added On: June 23rd, 2010]
- 050 International Stem Cell Corporation Names Charles J. Casamento to Board of Directors [Last Updated On: June 23rd, 2010] [Originally Added On: June 23rd, 2010]
- 051 International Stem Cell Corporation (ISCO.OB) Announces New Patent Issuance Under License Agreement [Last Updated On: June 25th, 2010] [Originally Added On: June 25th, 2010]
- 052 International Stem Cell Corporation (ISCO.OB) Announces New Patent Issuance Under License Agreement [Last Updated On: June 25th, 2010] [Originally Added On: June 25th, 2010]
- 053 Diabetes treated with Stem Cell Therapy [Last Updated On: June 25th, 2010] [Originally Added On: June 25th, 2010]
- 054 California Health Institute Interviews Jeffrey Janus - CEO of Lifeline Cell Technology [Last Updated On: June 29th, 2010] [Originally Added On: June 29th, 2010]
- 055 California Health Institute Interviews Jeffrey Janus - CEO of Lifeline Cell Technology [Last Updated On: June 29th, 2010] [Originally Added On: June 29th, 2010]
- 056 U.S. appeals court reinstates stem cell suit [Last Updated On: June 29th, 2010] [Originally Added On: June 29th, 2010]
- 057 Burn Victim Eye Sight Restored with Stem Cell Therapy [Last Updated On: June 29th, 2010] [Originally Added On: June 29th, 2010]
- 058 Treating Adult Artritis with Stem Cells Shows Incredible Promise [Last Updated On: June 30th, 2010] [Originally Added On: June 29th, 2010]
- 059 International Stem Cell Corporation - Excerpt from Agora Financial's Breakthrough Technology Alert by Patrick Cox [Last Updated On: July 1st, 2010] [Originally Added On: July 1st, 2010]
- 060 International Stem Cell Corporation - Excerpt from Agora Financial's Breakthrough Technology Alert by Patrick Cox [Last Updated On: July 1st, 2010] [Originally Added On: July 1st, 2010]
- 061 Melanoma-initiating cells identified [Last Updated On: July 2nd, 2010] [Originally Added On: July 2nd, 2010]
- 062 Melanoma-initiating cells identified [Last Updated On: July 2nd, 2010] [Originally Added On: July 2nd, 2010]
- 063 International Stem Cell Corporation and Sankara Nethralaya Launch Collaboration to Develop Stem Cell-Based Treatment for Corneal Vision Impairment [Last Updated On: July 8th, 2010] [Originally Added On: July 8th, 2010]
- 064 International Stem Cell Corporation and Sankara Nethralaya Launch Collaboration to Develop Stem Cell-Based Treatment for Corneal Vision Impairment [Last Updated On: July 8th, 2010] [Originally Added On: July 8th, 2010]
- 065 Two recent OA articles [Last Updated On: July 12th, 2010] [Originally Added On: July 12th, 2010]
- 066 Two recent OA articles [Last Updated On: July 12th, 2010] [Originally Added On: July 12th, 2010]
- 067 Innovative Researcher Vlog [Last Updated On: July 16th, 2010] [Originally Added On: July 16th, 2010]
- 068 Innovative Researcher Vlog [Last Updated On: July 16th, 2010] [Originally Added On: July 16th, 2010]
- 069 More about salinomycin [Last Updated On: July 19th, 2010] [Originally Added On: July 19th, 2010]
- 070 More about salinomycin [Last Updated On: July 19th, 2010] [Originally Added On: July 19th, 2010]
- 071 International Stem Cell Corporation Plans $10 Million Financing Through European Subsidiary [Last Updated On: July 23rd, 2010] [Originally Added On: July 23rd, 2010]
- 072 International Stem Cell Corporation Plans $10 Million Financing Through European Subsidiary [Last Updated On: July 23rd, 2010] [Originally Added On: July 23rd, 2010]
- 073 Irradiating brain's stem cell niche [Last Updated On: July 26th, 2010] [Originally Added On: July 26th, 2010]
- 074 Irradiating brain's stem cell niche [Last Updated On: July 26th, 2010] [Originally Added On: July 26th, 2010]
- 075 Prostate CSCs sensitive to gamma-tocotrienol? [Last Updated On: July 27th, 2010] [Originally Added On: July 27th, 2010]
- 076 Prostate CSCs sensitive to gamma-tocotrienol? [Last Updated On: July 27th, 2010] [Originally Added On: July 27th, 2010]
- 077 Researchers Study CSCs as Therapeutic Targets for Mesothelioma [Last Updated On: July 28th, 2010] [Originally Added On: July 28th, 2010]
- 078 Researchers Study CSCs as Therapeutic Targets for Mesothelioma [Last Updated On: July 28th, 2010] [Originally Added On: July 28th, 2010]
- 079 International Stem Cell Corporation and Sristi Biosciences Enter Distribution Agreement for Lifeline Cell Technology's Brand of Human Cell Culture... [Last Updated On: July 29th, 2010] [Originally Added On: July 29th, 2010]
- 080 Disagreement about melanoma CSCs [Last Updated On: July 29th, 2010] [Originally Added On: July 29th, 2010]